Navigation Links
Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
Date:1/24/2013

KANSAS CITY, Kan. and NEW YORK, Jan. 24, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced the appointment of Erick Lucera as Vice President of Corporate Development.  Mr. Lucera will leverage his broad experience managing investments in healthcare, as well as his network of industry contacts to facilitate business development and investment initiatives for Aratana.

Steven St. Peter , M.D., President and Chief Executive Officer of Aratana Therapeutics, stated, "Erick is well known in the healthcare industry and we are very excited to add him to our team.  His deep understanding of corporate strategy and proven ability to recognize and invest strategically in strong growth opportunities will be paramount to keeping Aratana on its current trajectory."

Mr. Lucera stated, "Aratana represents one of the most attractive investment models I've seen in my 15 years as a healthcare investor.  I am confident the human health industry is beginning to recognize the strategic importance and remarkable value in developing animal health strategies for their assets.  As part of my commitment to positioning Aratana as the partner of choice for these companies, I look forward to bringing in high-quality assets and delivering significant value through successful execution on our business initiatives."

Erick Lucera
Mr. Lucera has more than 15 years of diverse experience in the healthcare public equity markets.  Prior to joining Aratana, Mr. Lucera spent four years as Vice President and Healthcare Analyst at Eaton Vance Investment Managers.  From 2004 to 2007, Mr. Lucera was a Portfolio Manager at Intrepid Capital, where he successful
'/>"/>

SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
2. Aratana to Participate in Leerink Swanns November Management Access Days
3. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
4. Topokine Therapeutics Secures Financing from Schooner Capital to Advance Clinical Development of XAF5 Gel
5. PrimeMail, Prime Therapeutics mail-service pharmacy, receives URAC Reaccreditation
6. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
7. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
8. Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer
9. Fred Hutchinson Cancer Research Center Partners With GlaxoSmithKline to Develop Muscular Dystrophy Therapeutics
10. Northwest Biotherapeutics Announces Public Offering of Common Stock and Warrants, and Listing on NASDAQ
11. PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... Mass., Sept. 21 Echo Therapeutics, Inc. (OTC Bulletin ... needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal ... for transdermal drug delivery, today announced that it is ... transdermal biosensor for continuous lactate monitoring to be used ...
... Bionovo, Inc. (Nasdaq: BNVI, BNVID), a drug discovery and development ... oncology, today announced that Dr. Isaac Cohen, O.M.D., Chairman and ... Healthcare Conference at 4:00 p.m. ET on Tuesday, September 28, ... Palace hotel in New York City. Interested parties ...
Cached Medicine Technology:Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring 2Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring 3Bionovo to Present at the JMP Securities Healthcare Conference 2
(Date:4/17/2014)... Colic affects about one in five infants in the ... during the first several months after birth. Research into ... promise; however, the April 1, 2014 issue of the ... on a study, "Probiotics and Infant Colic," concluding that ... for infant colic did not reduce crying or ...
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
(Date:4/17/2014)... Calif.) An international team led by researchers at ... complex, which plays a key role in cell division, ... This is the first time the complex has been ... make cyclin B1/Cdk1 an excellent target to control cellular ... The research was published online today in the journal ...
(Date:4/17/2014)... by Cesar A. Arias, M.D., Ph.D., at The University ... identified a new superbug that caused a bloodstream infection ... April 17 issue of The New England Journal ... of a class of highly-resistant bacteria known as methicillin-resistant ... major cause of hospital and community-associated infections. The superbug ...
(Date:4/17/2014)... ribbon representing a disease. A pink ribbon is well known ... think of with lung cancer?, Although white has been identified ... black may be the only one they think fits., A ... smokers between the ages of 51 to 79 years old, ... these patients, the emotional toll it can have and how ...
Breaking Medicine News(10 mins):Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... Solutions Founder, Joins Schooner Healthcare Consulting Team, ... RN, CCM, a,leading thought leader in the case ... "I am delighted that Ms. Craig, architect of ... as Chief Knowledge Officer,",notes Mr. Garry Carneal, SHS ...
... may explain why some nonsmokers contract the disease, study says ... variant increases the risk of lung cancer, even in nonsmokers, ... the alpha1-antitrypsin gene double someones risk of developing lung cancer, ... help explain why some nonsmokers develop the disease, said study ...
... TransforMED Names Kevin Hutchinson to Inaugural Board of ... president and chief,executive officer, Kevin Hutchinson, has been ... for TransforMED LLC, a wholly owned subsidiary of ... provide,support and consulting services to primary care physicians ...
... Dermatology Clinic (ADC),Tustin announces today the appointment of Dr. ... Board of the American College of,Veterinary Dermatology (ACVD). The ... is the decision making body for the specialty College.,This ... Dr.,Muse being a liaison between the ACVD Executive Board ...
... the June issue of the Journal of Dental Research ... and Craniofacial Research (NIDCR) in expanding the understanding of, ... NIDCR Director Lawrence A. Tabak and Deputy Director A. ... the traditional research community can be best positioned for ...
... May 27 Family,Health International,s staff will make ... number of new publications at the annual,Global Health ... Shoreham Hotel in Washington, DC., Join FHI ... public health,impact of the recent violence in Kenya, ...
Cached Medicine News:Health News:Acuity Workflow Solutions(TM) Enhances Medical Case Management Process: 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 3Health News:Prematics CEO Joins Initiative to Advance More Coordinated, Connected Health Care 2Health News:Prematics CEO Joins Initiative to Advance More Coordinated, Connected Health Care 3Health News:Animal Dermatology Clinic Tustin Announces Dr. Russell Muse's Appointment as the Member-At-Large for the Executive Board of the American College of Veterinary Dermatology 2Health News:NIDCR strategies for future scientific success 2Health News:Family Health International Featured at Global Health Council Conference 2Health News:Family Health International Featured at Global Health Council Conference 3Health News:Family Health International Featured at Global Health Council Conference 4
All the advantages of Dr. Roy P. Finney's classic stent design with an open tip....
... Chlamydia Culture Confirmation provides ... of intracellular inclusions (elementary ... in tissue culture. ... in this kit is ...
... direct fluorescent assays (DFA) kit ... to provide clear, easy-to-read and ... Chlamydia antigens are detected ... the C. trachomatis major outer ...
... rubella IgG antibody in women prior to ... possible rubella viral infection during pregnancy. ... reduced the incidence of rubella epidemics, but ... of immune status, especially for women of ...
Medicine Products: